|
|
||||||||
American Journal of Clinical Nutrition, Vol 50, 269-273, Copyright © 1989 by The American Society for Clinical Nutrition, Inc
ORIGINAL RESEARCH COMMUNICATIONS |
JC Seidell, M Cigolini, P Deurenberg, A Oosterlee and G Doornbos
Department of Human Nutrition, Agricultural University, Wageningen, The Netherlands.
Eighty-five randomly selected women, all born in 1948, were studied. All were nonobese (body mass index [BMI], 23.3 +/- 0.3 (means +/- SD]). The relationships between three indicators of fat distribution (waist- hip, waist-thigh, and subscapular-triceps ratios) and hormonal and metabolic variables were studied. Increased androgenic activity (ratio of free testosterone [T] to total testosterone [free-total T ratio]) and degree of obesity (BMI) were independently related to increased waist-hip ratio. Waist-hip and waist-thigh ratios showed higher correlations with all metabolic variables than did the triceps- subscapular skinfold thickness ratio except for diastolic blood pressure. After adjustment for BMI and free-total T ratio, the waist- hip ratio was still significantly positively related to total cholesterol and C peptide and negatively to the HDL-total cholesterol ratio. In such multiple regression, BMI was independently related to insulin, C peptide, and diastolic blood pressure. The free-total T ratio was independently related to triglycerides. BMI and waist-hip ratio gave important complementary information about risk factors for diseases such as cardiovascular disease and diabetes mellitus.
This article has been cited by other articles:
![]() |
T. A. Sellers, J. Davis, J. R. Cerhan, R. A. Vierkant, J. E. Olson, V. S. Pankratz, J. D. Potter, and A. R. Folsom Interaction of Waist/Hip Ratio and Family History on the Risk of Hormone Receptor-defined Breast Cancer in a Prospective Study of Postmenopausal Women Am. J. Epidemiol., February 1, 2002; 155(3): 225 - 233. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Diamanti-Kandarakis, A. Mitrakou, S. Raptis, G. Tolis, and A. J. Duleba The Effect of a Pure Antiandrogen Receptor Blocker, Flutamide, on the Lipid Profile in the Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2699 - 2705. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |